Active Ingredients: Fluticasone Propionate + Salmeterol
Type: Metered-Dose Inhaler (MDI)
Class: ICS + LABA combination
Indications:
Bronchial asthma
COPD (chronic bronchitis, emphysema)
Use: Controller/maintenance inhaler
NOT for acute asthma attacks (not a rescue inhaler)
Bexitrol F MDI is a combination inhaler used for long-term management of asthma and chronic obstructive pulmonary disease (COPD).
It contains:
Fluticasone Propionate – an inhaled corticosteroid (ICS) that reduces airway inflammation
Salmeterol – a long-acting beta-agonist (LABA) that keeps airways open for up to 12 hours
This inhaler is designed for maintenance therapy, not for emergency relief. It helps prevent asthma attacks, reduces flare-ups, improves lung function, and maintains stable breathing over time.
Provides 12-hour long-lasting bronchodilation
Reduces airway inflammation and swelling
Helps prevent asthma attacks & nighttime symptoms
Reduces COPD exacerbations
Improves breathing capacity and overall lung performance
Suitable for long-term management of persistent asthma
